UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.359

Sortiert nach

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

Nature reviews. Cancer, 2023-03, Vol.23 (3), p.173

2023

Link zum Volltext

Verfügbarkeit prüfen

Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma

International journal of molecular sciences, 2020-12, Vol.22 (1), p.240

2020

Link zum Volltext

Verfügbarkeit prüfen

The Oral Microbiome and Cancer

Frontiers in immunology, 2020-10, Vol.11, p.591088-591088

2020

Link zum Volltext

Verfügbarkeit prüfen

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma

Frontiers in immunology, 2021-11, Vol.12, p.781466-781466

2021

Link zum Volltext

Verfügbarkeit prüfen

STAT1 inhibits T‐cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma

International journal of cancer, 2020-03, Vol.146 (6), p.1717-1729

2020

Link zum Volltext

Verfügbarkeit prüfen

Carboplatin and paclitaxel after anti‐PD‐1 or anti‐PD‐L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neck

Head & neck, 2024-02, Vol.46 (2), p.321-327

2024

Link zum Volltext

Verfügbarkeit prüfen

Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update

Drugs (New York, N.Y.), 2023-02, Vol.83 (3), p.217-248

2023

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance

Neoplasia (New York, N.Y.), 2021-01, Vol.23 (1), p.118-128

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes

Clinical cancer research, 2021-10, Vol.27 (19), p.5168-5187

2021

Link zum Volltext

Verfügbarkeit prüfen

Oral cavity cancer in young, non-smoking, and non-drinking patients: A contemporary review

Critical reviews in oncology/hematology, 2023-10, Vol.190, p.104112-104112, Article 104112

2023

Link zum Volltext

Verfügbarkeit prüfen

Salvage total laryngectomy for squamous cell carcinoma of the larynx and hypopharynx: Validated prognostic nomograms predicting oncological outcomes

Head & neck, 2024-01, Vol.46 (1), p.46-56

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer

Clinical cancer research, 2022-04, Vol.28 (7), p.1335-1344

2022

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review

International journal of molecular sciences, 2021-03, Vol.22 (5), p.2561

2021

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas

Annals of oncology, 2018-02, Vol.29 (2), p.466-471

2018

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab in combination with chemoradiotherapy in patients with head and neck squamous cell carcinoma: Results from the Phase 1 CLOVER study

Head & neck, 2024-05, Vol.46 (5), p.1152-1159

2024

Link zum Volltext

Verfügbarkeit prüfen

Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy

Scientific reports, 2019-08, Vol.9 (1), p.11992-17, Article 11992

2019

Link zum Volltext

Verfügbarkeit prüfen

Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity

JNCI : Journal of the National Cancer Institute, 2019-03, Vol.111 (3), p.233-244

2019

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus infection among head and neck squamous cell carcinomas in southern China

PloS one, 2019-09, Vol.14 (9), p.e0221045-e0221045

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma

BMC cancer, 2022-12, Vol.22 (1), p.1336-1336, Article 1336

2022

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial

Clinical cancer research, 2023-05, Vol.29 (10), p.1906

2023

Link zum Volltext

Verfügbarkeit prüfen

Photodynamic therapy for squamous cell carcinoma of the head and neck: narrative review focusing on photosensitizers

Lasers in medical science, 2022-04, Vol.37 (3), p.1441-1470

2022

Link zum Volltext

Verfügbarkeit prüfen

Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes

Oral oncology, 2022-07, Vol.130, p.105909-105909, Article 105909

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma

Oral oncology, 2022-12, Vol.135, p.106219, Article 106219

2022

Link zum Volltext

Verfügbarkeit prüfen

Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy

Frontiers in immunology, 2023-04, Vol.14, p.1135489-1135489

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.359

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.188)
Mit Volltextzugriff
(1.999)

Publikationsform

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(2.305)
Science & Technology
(2.036)
Life Sciences & Biomedicine
(1.987)
Male
(1.602)
Middle Aged
(1.411)
Female
(1.363)
Aged
(1.175)
Adult
(911)
Oncology
(866)
Otorhinolaryngology
(768)
Biological And Medical Sciences
(718)
Medical Sciences
(716)
Tumors
(599)
Carcinoma, Squamous Cell - Radiotherapy
(574)
Head And Neck Cancer
(569)
Squamous Cell Carcinoma
(530)
Carcinoma, Squamous Cell - Pathology
(521)
Carcinoma, Squamous Cell - Etiology
(507)
Head And Neck Neoplasms - Radiotherapy
(496)
Surgery
(494)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma

The Oral Microbiome and Cancer

Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma

STAT1 inhibits T‐cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma

Carboplatin and paclitaxel after anti‐PD‐1 or anti‐PD‐L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neck

Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update

Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance

Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes

Oral cavity cancer in young, non-smoking, and non-drinking patients: A contemporary review

Salvage total laryngectomy for squamous cell carcinoma of the larynx and hypopharynx: Validated prognostic nomograms predicting oncological outcomes

Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer

MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review

Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas

Durvalumab in combination with chemoradiotherapy in patients with head and neck squamous cell carcinoma: Results from the Phase 1 CLOVER study

Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy

Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity

Human papillomavirus infection among head and neck squamous cell carcinomas in southern China

Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma

Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial

Photodynamic therapy for squamous cell carcinoma of the head and neck: narrative review focusing on photosensitizers

Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes

A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma

Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy

Suchergebnisse filtern